XML 36 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Net Sales $ 18,240 $ 17,438 $ 36,038 $ 34,128
Cost of Products Sold 8,869 8,919 17,592 17,403
Selling, General and Administrative Expense 4,889 4,623 9,674 9,275
Operating Income 4,482 3,896 8,772 7,450
Interest Expense (100) (138) (208) (267)
Interest Income 36 63 94 116
Other Non-operating Income/(Loss), Net 114 95 217 557
Earnings/(Loss) from Continuing Operations Before Income Taxes 4,532 3,916 8,875 7,856
Income Taxes on Continuing Operations 789 700 1,515 1,429
Net Earnings 3,743 3,216 7,360 6,427
Net Income (Loss) Attributable to Noncontrolling Interest $ 26 $ 22 $ 50 $ 34
Basic Net Earnings Per Common Share        
Basic Net Earnings Per Common Share [1],[2] $ 1.47 $ 1.25 $ 2.88 $ 2.51
Diluted Net Earnings Per Common Share        
Diluted Net Earnings Per Common Share [1],[2] $ 1.41 $ 1.22 $ 2.77 $ 2.44
Diluted Weighted Average Common Shares Outstanding 2,630.1 2,623.0 2,638.8 2,617.6
Noncontrolling Interest [Member]        
Net Income (Loss) Attributable to Noncontrolling Interest $ 26 $ 22 $ 50 $ 34
Retained Earnings [Member]        
Net Earnings Attributable to Procter & Gamble $ 3,717 $ 3,194 $ 7,310 $ 6,393
[1] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[2] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.